Evidence map›Paper›PMID 40093534›Full record

ArticleFrontiers in cellular and infection microbiology2025

Comparative study of the inhibitory effects of different antibiotic administration routes on bone healing in a rat tibial infection model.

Xiaoyu Han, Wei Wang, Zengli Shen, Lisong Lv, Bingyuan Lin, Haiyong Ren, Yiyang Liu, Qiaofeng Guo, Huang Kai, Xiang Wang

Abstract readComparative Study
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xiaoyu HanTongde Hospital of Zhejiang Province, Hangzhou, China.
Wei WangTongde Hospital of Zhejiang Province, Hangzhou, China.
Zengli ShenTongde Hospital of Zhejiang Province, Hangzhou, China.
Lisong LvTongde Hospital of Zhejiang Province, Hangzhou, China.
Bingyuan LinTongde Hospital of Zhejiang Province, Hangzhou, China.
Haiyong RenTongde Hospital of Zhejiang Province, Hangzhou, China.
Yiyang LiuTongde Hospital of Zhejiang Province, Hangzhou, China.
Qiaofeng GuoTongde Hospital of Zhejiang Province, Hangzhou, China.
Huang KaiTongde Hospital of Zhejiang Province, Hangzhou, China.
Xiang WangTongde Hospital of Zhejiang Province, Hangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study aimed to evaluate the effectiveness of intravenous versus oral antibiotic treatments in managing bone infections, particularly osteomyelitis, using a rat tibial infection model. Methods: A tibial bone infection model was established in twelve-week-old Wistar rats via injection of Results: Blood analysis showed significant reductions in white blood cell count and pro-inflammatory cytokines in the intravenous treatment groups, especially with vancomycin. μCT imaging revealed better preservation of bone structure in intravenous treatment groups, while oral treatments resulted in more pronounced structural deterioration. Microbial analysis confirmed a lower bacterial load in the intravenous groups, particularly vancomycin, compared to oral treatments. Histological analysis revealed reduced inflammation, lower fibrosis, and minimal bacterial presence in intravenous groups. Osteoclast activity was notably reduced in the vancomycin and cefazolin groups, indicating better control of bone resorption. Conclusion: Intravenous administration of vancomycin demonstrated superior efficacy in controlling bone infection, reducing inflammation, and preserving bone structure compared to oral treatments. While ciprofloxacin and the ciprofloxacin-rifampin combination showed some efficacy, they were less effective than intravenous vancomycin, likely due to lower bioavailability and insufficient drug penetration in bone tissue.

Indexed as

Anti-Bacterial AgentsOsteomyelitisStaphylococcal InfectionsTibiaAdministration, IntravenousAdministration, OralAnimalsCefazolinCiprofloxacinCytokinesDisease Models, AnimalMaleRatsRats, WistarRifampinStaphylococcus aureusAnti-Bacterial AgentsCefazolinCiprofloxacinCytokinesRifampinVancomycinantibiotic treatmentbone healingbone infectionosteomyelitisrat model

Identifiers

PMID40093534
PMCPMC11907719

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.